Jazz Pharmaceuticals (JAZZ) Revenue Growth (1y) (2011 - 2026)
Jazz Pharmaceuticals (JAZZ) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | 96.43% |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.94 Bn | 934.80 Mn | 19.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.06% |
| Dec 31, 2025 | 10.09% |
| Sep 30, 2025 | 6.74% |
| Jun 30, 2025 | 2.14% |
| Mar 31, 2025 | -0.46% |
| Dec 31, 2024 | 7.53% |
| Sep 30, 2024 | 8.52% |
| Jun 30, 2024 | 6.95% |
| Mar 31, 2024 | 1.03% |
| Dec 31, 2023 | 4.10% |
| Sep 30, 2023 | 3.35% |
| Jun 30, 2023 | 2.62% |
| Mar 31, 2023 | 9.72% |
| Dec 31, 2022 | 8.41% |
| Sep 30, 2022 | 12.23% |
| Jun 30, 2022 | 24.08% |
| Mar 31, 2022 | 33.93% |
| Dec 31, 2021 | 34.74% |
| Sep 30, 2021 | 39.48% |
| Jun 30, 2021 | 33.67% |